TEAD1
TEAD1 (TEA domain transcription factor 1, also known as TEF-1 and TCF13) is a nuclear transcription factor and a key effector of the Hippo signalling pathway. It mediates YAP1 and WWTR1/TAZ-driven gene expression and is involved in cardiac development. Browse Assay Genie's current range of TEAD1 research reagents below, or read on for the biology behind the target.
TEAD1 is a transcription factor that plays a key role in the Hippo signalling pathway, which controls organ size and acts in tumour suppression by restricting proliferation and promoting apoptosis. The core of the pathway is a kinase cascade. MST1/MST2, in complex with SAV1, phosphorylates and activates LATS1/2 in complex with MOB1. LATS1/2 in turn phosphorylates and inactivates the YAP1 oncoprotein and WWTR1/TAZ. TEAD1 acts by mediating the gene expression programmes of YAP1 and WWTR1/TAZ, and so regulates cell proliferation, migration and induction of epithelial mesenchymal transition (EMT).
The TEAD1 protein binds specifically and cooperatively to the SPH and GT-IIC 'enhansons' (5'-GTGGAATGT-3') and activates transcription in vivo in a cell-specific manner. This activation appears to depend on a limiting, cell-specific transcriptional intermediary factor (TIF). It also binds the M-CAT motif and is involved in cardiac development. The TEAD1 gene encodes a ubiquitous transcriptional enhancer factor of the TEA/ATTS domain family. It directs transactivation of a wide variety of genes and, in placental cells, can also act as a transcriptional repressor. Further transcript variants have been described, although their full-length natures have not been experimentally verified. The mouse ortholog is Tead1.
The protein is also called TEF-1 and TCF13, and the gene was previously named TEA domain family member 1 (SV40 transcriptional enhancer factor). Mutations in the TEAD1 gene cause Sveinsson's chorioretinal atrophy, which explains the earlier symbols atrophia areata and peripapillary chorioretinal degeneration. HGNC places it in the TEA domain transcription factors group.
TEAD1 mediates YAP1 and WWTR1/TAZ-dependent gene expression downstream of the MST1/MST2 and LATS1/2 kinase cascade.
TEAD1 regulates cell proliferation, migration and epithelial mesenchymal transition induction through its role as a Hippo pathway effector.
TEAD1 is involved in cardiac development and binds the M-CAT motif, making it a focus for transcriptional studies of the heart.
Mutations in the TEAD1 gene cause Sveinsson's chorioretinal atrophy, linking this transcription factor to inherited eye disease.
TEAD1 is a nuclear transcription factor in the Hippo pathway. It mediates gene expression driven by YAP1 and WWTR1/TAZ, thereby regulating cell proliferation, migration and EMT induction. It also binds the SPH and GT-IIC enhansons and the M-CAT motif, and is involved in cardiac development.
TEAD1 is also known as TEF-1 (UniProt: transcriptional enhancer factor TEF-1) and TCF13. Earlier symbols include AA, and earlier names include TEA domain family member 1 (SV40 transcriptional enhancer factor) and atrophia areata, peripapillary chorioretinal degeneration. Additional transcript variants have been described.
Yes. According to the NCBI Gene summary, mutations in the TEAD1 gene cause Sveinsson's chorioretinal atrophy. Through the Hippo pathway, it also acts with YAP1 and WWTR1/TAZ, which are involved in proliferation control. The mouse ortholog is Tead1; check the datasheet of any product for its validated reactivity.
Other TEA domain transcription factors that work alongside TEAD1 in Hippo pathway signalling.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P28347; product specifications from Assay Genie datasheets.